CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Operating expenses
Research and development	$ 2,292	$ 2,353	$ 9,332	$ 6,302
General and administrative	984	1,193	3,478	3,613
Total operating expenses	3,276	3,546	12,810	9,915
Net operating loss	(3,276)	(3,546)	(12,810)	(9,915)
Other income
Change in fair value of warrant liability	72		72
Interest income	5	11	32	13
Total other income	77	11	104	13
Net loss	$ (3,199)	$ (3,535)	$ (12,706)	$ (9,902)
Net loss per share, basic	$ (0.32)	$ (0.49)	$ (1.47)	$ (1.38)
Weighted average number of common shares outstanding, basic	10,053	7,160	8,665	7,160
Net loss per share, diluted	$ (0.32)	$ (0.49)	$ (1.47)	$ (1.38)
Weighted average number of common shares outstanding, diluted	10,053	7,160	8,665	7,160